Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.

Boufraqech, Myriem; Nilubol, Naris

Boufraqech, Myriem; Nilubol, Naris.

Afiliação

Boufraqech M; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20817, USA.
Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20817, USA.

Cancers (Basel) ; 11(12)2019 Dec 10.

Article em En | MEDLINE | ID: mdl-31835496

Palavras-chave

genomic; methylation; microRNA; proteomic; thyroid cancer

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966476
https://dx.doi.org/10.3390/cancers11121988

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966476
https://dx.doi.org/10.3390/cancers11121988

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article